Physician

Harris V.k Naina, MD

According to 2025 Medicare claims, Harris Naina, MD (NPI: 1871506733) practices hematology/oncology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1033386578; TIN: 752131429) and primary practice location at 76104-2154. Naina is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.

Naina's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 482 traditional Medicare patients, billed 100,582 HCPCS/CPT codes, and received $2,094,948 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,402 prescription claims across 207 beneficiaries totaling $4,939,796 in drug costs, led by Tibsovo (Ivosidenib). 2019 DME data shows 23 claims. Open Payments data shows 53 records totaling $60,058. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $31,330 to $2,094,948. Similarly, Part D prescription costs have moved sharply higher in recent years, from $478,778 to $4,939,796. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.0M$2.1M2015 Medicare payment: $31,330 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $125,353 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $137,676 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $39,863 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $688,000 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,369,415 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,710,851 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,143,306 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,146,957 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,094,948 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015129389$31,330
20163391,342$125,353
20173233,393$137,676
2018969,887$39,863
201931834,047$688,000
202049360,934$1,369,415
202147676,570$1,710,851
202245960,214$1,143,306
202339948,261$1,146,957
2024482100,582$2,094,948

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.5M$4.9M2015 Drug cost: $478,778 (USD; Tot_Drug_Cst)2016 Drug cost: $28,785 (USD; Tot_Drug_Cst)2017 Drug cost: $147,126 (USD; Tot_Drug_Cst)2018 Drug cost: $556,552 (USD; Tot_Drug_Cst)2019 Drug cost: $707,731 (USD; Tot_Drug_Cst)2020 Drug cost: $1,472,370 (USD; Tot_Drug_Cst)2021 Drug cost: $2,600,499 (USD; Tot_Drug_Cst)2022 Drug cost: $2,780,699 (USD; Tot_Drug_Cst)2023 Drug cost: $2,932,219 (USD; Tot_Drug_Cst)2024 Drug cost: $4,939,796 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201558498$478,778
201647152$28,785
201722134$147,126
201828157$556,552
201971337$707,731
202099827$1,472,370
2021130893$2,600,499
20221471,076$2,780,699
20231711,077$2,932,219
20242071,402$4,939,796

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$5.6K$11K2015 Medicare payment: $11,215 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $904 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $976 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R30$11,215
2016N/RN/RN/R
2017N/R47$904
2018N/RN/RN/R
2019N/R23$976
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more163328$94
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's195493$12
80053Blood test, comprehensive group of blood chemicals160557$10
36415Insertion of needle into vein for collection of blood sample178698$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count164542$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TibsovoIvosidenib25750$831,116
RevlimidLenalidomide531,431$765,436
JakafiRuxolitinib Phosphate391,163$656,694
VenclextaVenetoclax401,172$576,122
LenalidomideLenalidomide34910$401,363

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.43$25,927BeiGene USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.10$34,131Janssen Research & Development, LLC
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Harris V.k Naina, MD?

Tedicare shows public-source Medicare data for Harris V.k Naina, MD (NPI 1871506733), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Harris V.k Naina, MD have ACO affiliation data?

Harris V.k Naina, MD is shown with ACO affiliation data for UT Southwestern Accountable Care Network (REACH, ACO ID D0211).

What billing organization is linked to Harris V.k Naina, MD?

Harris V.k Naina, MD is linked to TEXAS ONCOLOGY PA (billing NPI 1033386578) in the available physician profile data.

Does Harris V.k Naina, MD have Open Payments data?

Harris V.k Naina, MD has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.